Authors:
Drost, JB
Scaringe, WA
Jaloma-Cruz, AR
Li, XM
Ossa, DF
Kasper, CK
Sommer, SS
Citation: Jb. Drost et al., Novel hotspot detector software reveals a non-CpG hotspot of germline mutation in the factor IX gene (F9) in Latin Americans, HUM MUTAT, 16(3), 2000, pp. 203-210
Authors:
Liebman, HA
Rosenwald-Zuckerman, T
Retzios, A
Yasmin, S
Kasper, CK
Citation: Ha. Liebman et al., Kinetics of factor IX activity differ from that of factor IX antigen in patients with haemophilia B receiving high-purity factor IX replacement, HAEMOPHILIA, 5(3), 1999, pp. 174-180
Authors:
Seremetis, S
Lusher, JM
Abildgaard, CF
Kasper, CK
Allred, R
Hurst, D
Citation: S. Seremetis et al., Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A: conclusions of a 5-year study of home therapy, HAEMOPHILIA, 5(1), 1999, pp. 9-16
Authors:
Ketterling, RP
Drost, JB
Scaringe, WA
Liao, DZ
Liu, JZ
Kasper, CK
Sommer, SS
Citation: Rp. Ketterling et al., Reported in vivo splice-site mutations in the factor IX gene: Severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations, HUM MUTAT, 13(3), 1999, pp. 221-231
Authors:
Ketterling, RP
Vielhaber, E
Li, XM
Drost, J
Schaid, DJ
Kasper, CK
Phillips, JA
Koerper, MA
Kim, H
Sexauer, C
Gruppo, R
Ambriz, R
Paredes, R
Sommer, SS
Citation: Rp. Ketterling et al., Germline origins in the human F9 gene: frequent G : C--> A : T mosaicism and increased mutations with advanced maternal age, HUM GENET, 105(6), 1999, pp. 629-640
Authors:
Lusher, JM
Roberts, HR
Davignon, G
Joist, JH
Smith, H
Shapiro, A
Laurian, Y
Kasper, CK
Mannucci, PM
Citation: Jm. Lusher et al., A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors, HAEMOPHILIA, 4(6), 1998, pp. 790-798